Acute consumption of dietary nitrate (as beetroot juice) has been shown to increase exercise and decrease systemic blood pressure in multiple populations, including COPD. The chronic effect of dietary nitrate in obstructive sleep apnea syndrome (OSAS) has not been reported.
Acute consumption of dietary nitrate (as beetroot juice) has been shown to increase exercise and decrease systemic blood pressure in multiple populations, including COPD. The chronic effect of dietary nitrate in OSAS has not been reported. The investigators hypothesize that chronic nitrate consumption might increase exercise tolerance, and exhaled NO but decrease blood pressure and have little impact on quality of life and pulmonary function. This study is a randomized, double-blind placebo-controlled, crossover trial. At baseline, mid-point and endpoint exercise tolerance, pulmonary function, quality of life and ambulatory blood pressure will be assessed in conjunction with demographics and blood draw. After baseline measures, each subject will be randomized to consume nitrate rich beetroot juice for 14 consecutive nights when assessments will be repeated followed by 14 nights of placebo and endpoint assessments or the converse.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Enrollment
8
140ml of nitrate rich beetroot juice provides 12.9mmol nitrate and will be consumed on a daily basis during the intervention by the study subjects.
140ml of nitrate depleted beetroot juice provides 0.5mmol nitrate and will be consumed on a daily basis during the intervention by the study subjects.
Respiratory & Sleep Diagnostics Department, Connolly Hospital
Dublin, Ireland
Change in incremental shuttle walk test distance
Time frame: Day 1, day 15 and day 29
Change in plasma nitrate
Assessed by chemiluminescence
Time frame: Day 1, day 15 and day 29
Change in ambulatory blood pressure
Time frame: Day 1, day 15 and day 29
Change in quality of life
Quality of Life will be assessed with the Clinical COPD Questionnaire
Time frame: Day 1, day 15 and day 29
Change in forced expiratory volume
Assessed by spirometry
Time frame: Day 1, day 15 and day 29
Change in inflammatory markers
Assessed by C-reactive protein
Time frame: Day 1, day 15 and day 29
Change in forced vital capacity
Assessed by spirometry
Time frame: Day 1, day 15 and day 29
Change in plasma nitrate and nitrite
Assessed by chemiluminescence
Time frame: Day 1, day 15 and day 29
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.